Rallybio Corp Files 2024 Proxy Statement

Ticker: RLYB · Form: DEF 14A · Filed: Apr 7, 2025 · CIK: 1739410

Rallybio Corp DEF 14A Filing Summary
FieldDetail
CompanyRallybio Corp (RLYB)
Form TypeDEF 14A
Filed DateApr 7, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, shareholder-meeting

Related Tickers: RLYB

TL;DR

Rallybio's 2024 proxy statement is out, shareholders vote soon.

AI Summary

Rallybio Corporation filed its DEF 14A proxy statement on April 7, 2025, for the fiscal year ending December 31, 2024. The filing details the company's governance and executive compensation practices. Key information regarding shareholder proposals and director elections will be presented to shareholders for their vote.

Why It Matters

This filing provides shareholders with crucial information about the company's leadership, executive compensation, and voting matters, enabling informed participation in corporate governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently present new risks.

Key Players & Entities

  • Rallybio Corp (company) — Registrant
  • 234 Church Street, Suite 1020, New Haven, CT 06510 (address) — Company Business and Mail Address
  • 203-859-3820 (phone) — Company Business Phone
  • 123124 (date) — Fiscal Year End
  • 04072025 (date) — Filing Date

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to provide shareholders with information they need to vote on matters at an upcoming shareholder meeting, such as the election of directors and executive compensation.

When is Rallybio Corporation's fiscal year end?

Rallybio Corporation's fiscal year ends on December 31.

What is the filing date of this DEF 14A statement?

This DEF 14A statement was filed on April 7, 2025.

Where is Rallybio Corporation's principal executive office located?

Rallybio Corporation's principal executive office is located at 234 Church Street, Suite 1020, New Haven, CT 06510.

What is the SEC file number for Rallybio Corporation?

The SEC file number for Rallybio Corporation is 001-40693.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 7, 2025 regarding Rallybio Corp (RLYB).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.